DRIVEN BY PURPOSE, DEFINED BY GENEROSITY AND GUIDED BY A VISION FOR BETTER HEALTH
With
Adrian Cosenza, CEO
Australian Orthopaedic Association (AOA) &
CEO, AOA Research Foundation & Co-CEO
Australia New Zealand College of Orthopaedic Surgeons (ANZCOS) &
Chair, Australian Ethical Health Alliance (AEHA) &
Chair, Australia and New Zealand Sarcoma Association (ANZSA)
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Sydney | November 2026
Adrian Cosenza is an experienced Chief Executive Officer and seasoned director, having served in an executive capacity in three industries including medical education, technology, and banking and finance and in a director capacity on over 15 boards across five industry sectors in four country jurisdictions.
Adrian is the Chief Executive Officer and Company Secretary of the Australian Orthopaedic Association (AOA), having joined AOA in July 2010 and is also the Chief Executive Officer and Company Secretary of AOA Research Foundation, chair of the Australia and New Zealand Sarcoma Association and chair of the Australian Ethical Health Alliance (AEHA). Since 2016 Adrian has served as the Australasian ambassador for the International Medical Education Leaders Forum convened by the Royal College of Physicians and Surgeons of Canada. Adrian is also the first national CEO CookOff Brand Ambassador for OzHarvest.
Over the past ten years, Adrian has led the modernisation of AOA into a vibrant and respected leader in the field of orthopaedics while also leading the establishment of Australian Ethical Health Alliance (AEHA), Australia’s consensus framework group with over 76 signatories representing over 1 million healthcare professionals and over 25m patients/consumers. Adrian was elected inaugural Chair of AEHA in 2019 and re-elected for a second term in 2023.
Adrian has three degrees, a Bachelor Commerce and Masters of Commerce from the University of New South Wales and an MBA from IMD Lausanne Switzerland. Adrian is a fellow of three professional bodies Australian Institute of Company Directors, Financial Services Institute, and CPA Australia
Source: Supplied
-
Recognising service in health regulation
In April 2023, Professor John Skerritt retired from his position of Deputy Secretary Health Products Regulation Group, a role he has been in since 2012. During his time at the TGA he had line responsibility for over 1200 staff involved in the regulation of therapeutic goods, regulation of gene technology and industrial chemicals and control of drug import, export and production.
At this year’s ARCS 2023 Conference, ARCS Australia CEO Dr Shanny Dyer paid tribute to Professor Skerritt and his service to the Australian health industry. She led a tribute with fellow industry heads, Elizabeth de Somer, CEO, Medicines Australia, Anne Harris, Managing Director, Pfizer Australia & New Zealand, Deon Schoombie, CEO, Consumer Healthcare Products Australia, Ian Burgess, CEO, Medical Technology Association of Australia and Arthur Brandwood, President ARCS Australia.
-
Landmark research projects tackle critical issues in emergency healthcare
For two decades, the demand for emergency department services in Australia has outpaced population growth and wait times have increased. In 2022-2023 more than 8.8 million emergency department presentations occurred nationwide.
While demand is a contributing factor, EDs are currently being impacted by various factors across the entire health system.
The Emergency Medicine Foundation (EMF) is a non-profit organisation funding innovative Australian research that improves the way people are cared for in a medical emergency. The aim of the research is to deliver better and more effective health services to save lives and money.
-
Clinical trial site in primary care setting open for novel therapies in psychiatry
Over the past decade, Paratus has been involved in over 200 clinical trials across 4 clinical site locations. Now a fifth site, the newly opened Melbourne site will cater to both primary care and psychiatry, specifically designed for psychedelic studies.
The new Melbourne site will be a focused on primary care studies specifically expanding access to psychiatric research, a growing area of unmet need. Australian Health Journal met with 3 recent hires brought in to support clinical trials across the organisation and in psychiatry in Melbourne.
